Actively Recruiting
Unsupervised Therapy After Stroke in the Home Setting with a Hand Rehabilitation Device (ReHandyBot)
Led by Swiss Federal Institute of Technology · Updated on 2024-11-01
15
Participants Needed
1
Research Sites
124 weeks
Total Duration
On this page
Sponsors
S
Swiss Federal Institute of Technology
Lead Sponsor
C
Clinica Hildebrand Brissago
Collaborating Sponsor
AI-Summary
What this Trial Is About
The ReHandyBot is a robot for hand rehabilitation after stroke. The aims of this study are (1) to investigate the feasibility of unsupervised therapy with the ReHandyBot with stroke inpatients, first in a rehabilitation clinic and then at participants' home, (2) to evaluate the usability of the ReHandyBot (user interface, implemented exercises, and gaming environment, which were adapted for independent usage), and (3) to quantify the dose of additional robotic therapy that patients perform without supervision. The study consists of two primary phases. The first is a familiarization phase performed at the clinic, where therapists teach to the participants how to perform the exercises with the robot. Then, if capable of training with the robot safely, after discharge from the clinic participants can bring the robot home and autonomously train with it. The hypothesis is that unsupervised therapy might be a possible way to increase therapy dose for stroke patients, with the potential to further improve recovery of hand function, with minimal additional burden for therapists and for the healthcare system.
CONDITIONS
Official Title
Unsupervised Therapy After Stroke in the Home Setting with a Hand Rehabilitation Device (ReHandyBot)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Age between 18 and 90 years
- Acute or subacute stroke within 12 weeks of onset
- Pre-stroke modified Rankin score of 1 or less
- NIH Stroke Scale score of 1 or more in motor, sensory, or ataxia items
- Enough space at home to set up the ReHandyBot device
You will not qualify if you...
- Modified Ashworth Scale greater than 2 in shoulder, forearm, elbow, wrist, or finger muscles
- Moderate to severe aphasia (Goodglass-Kaplan's scale less than 3)
- Moderate to severe cognitive deficits (LCF-R less than 9)
- Upper limb impairment due to other conditions
- Severe pain in affected arm (VAS pain score 5 or higher)
- Other medical conditions interfering with the study
- Presence of pacemakers or other active implants
- Planned discharge to assisted living or care home
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinica Hildebrand Centro di riabiliazione Brissago
Brissago, Canton Ticino, Switzerland, 6614
Actively Recruiting
Research Team
G
Giada Devittori, M. Sc.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here